ODAPC Revises “What Employers Need to Know about DOT Drug and Alcohol Testing” Handbook
June 2, 2015
Frequently Asked Questions About Drug Testing in Schools
October 1, 2014
Colorado Supreme Court Rules In Favor of Employer Regarding Medical Marijuana
June 19, 2015
Three Synthetic Cannabinoids Temporarily Placed as Schedule I Drugs
February 20, 2015
Effective Jan. 30, 2015, the Administrator of the Drug Enforcement Administration (DEA) issued its final order to temporarily schedule three synthetic cannabinoids (SCs) into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA).
The substances are: (1) N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-(cyclohexylmethyl)- 1H-indazole-3-carboxamide (‘‘AB– CHMINACA’’); (2) N-(1-amino-3-methyl- 1-oxobutan-2-yl)-1-pentyl-1H-indazole- 3-carboxamide (‘‘AB–PINACA’’); and (3) [1-(5-fluoropentyl)-1H-indazol-3- yl](naphthalen-1-yl)methanone (‘‘THJ–2201’’). This action is based on a finding by the Administrator that the placement of these synthetic cannabinoids and their optical, positional, and geometric isomers, salts, and salts of isomers into schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, or possess), or propose to handle these SCs.
For more information, contact Imelda L. Paredes, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812.